MBL2 and infectious disease: The sui generis mode of action of mannose-binding lectins such as GRFT, SVN, CV-N, OAA, and MVL against important pathogens has prompted the development of these molecules as potential therapeutics or prophylactic drugs to target single or multiple infectious diseases.